Literature DB >> 27203376

Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel.

Anja O Paatero1, Juho Kellosalo1, Bryan M Dunyak2, Jehad Almaliti3, Jason E Gestwicki2, William H Gerwick3, Jack Taunton4, Ville O Paavilainen5.   

Abstract

Apratoxin A is a cytotoxic natural product that prevents the biogenesis of secretory and membrane proteins. Biochemically, apratoxin A inhibits cotranslational translocation into the ER, but its cellular target and mechanism of action have remained controversial. Here, we demonstrate that apratoxin A prevents protein translocation by directly targeting Sec61α, the central subunit of the protein translocation channel. Mutagenesis and competitive photo-crosslinking studies indicate that apratoxin A binds to the Sec61 lateral gate in a manner that differs from cotransin, a substrate-selective Sec61 inhibitor. In contrast to cotransin, apratoxin A does not exhibit a substrate-selective inhibitory mechanism, but blocks ER translocation of all tested Sec61 clients with similar potency. Our results suggest that multiple structurally unrelated natural products have evolved to target overlapping but non-identical binding sites on Sec61, thereby producing distinct biological outcomes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27203376     DOI: 10.1016/j.chembiol.2016.04.008

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  38 in total

1.  Biosynthesis of t-Butyl in Apratoxin A: Functional Analysis and Architecture of a PKS Loading Module.

Authors:  Meredith A Skiba; Andrew P Sikkema; Nathan A Moss; Andrew N Lowell; Min Su; Rebecca M Sturgis; Lena Gerwick; William H Gerwick; David H Sherman; Janet L Smith
Journal:  ACS Chem Biol       Date:  2018-05-08       Impact factor: 5.100

Review 2.  Advances in exploring the therapeutic potential of marine natural products.

Authors:  Xiao Liang; Danmeng Luo; Hendrik Luesch
Journal:  Pharmacol Res       Date:  2019-07-25       Impact factor: 7.658

3.  A Maldiisotopic Approach to Discover Natural Products: Cryptomaldamide, a Hybrid Tripeptide from the Marine Cyanobacterium Moorea producens.

Authors:  Robin B Kinnel; Eduardo Esquenazi; Tiago Leao; Nathan Moss; Emily Mevers; Alban R Pereira; Emily A Monroe; Anton Korobeynikov; Thomas F Murray; David Sherman; Lena Gerwick; Pieter C Dorrestein; William H Gerwick
Journal:  J Nat Prod       Date:  2017-04-27       Impact factor: 4.050

Review 4.  Membrane Protein Integration and Topogenesis at the ER.

Authors:  Martin Spiess; Tina Junne; Marco Janoschke
Journal:  Protein J       Date:  2019-06       Impact factor: 2.371

Review 5.  Leveraging Chemotype-Specific Resistance for Drug Target Identification and Chemical Biology.

Authors:  Tarun M Kapoor; Rand M Miller
Journal:  Trends Pharmacol Sci       Date:  2017-10-13       Impact factor: 14.819

6.  A Mononuclear Iron-Dependent Methyltransferase Catalyzes Initial Steps in Assembly of the Apratoxin A Polyketide Starter Unit.

Authors:  Meredith A Skiba; Andrew P Sikkema; Nathan A Moss; Collin L Tran; Rebecca M Sturgis; Lena Gerwick; William H Gerwick; David H Sherman; Janet L Smith
Journal:  ACS Chem Biol       Date:  2017-11-14       Impact factor: 5.100

Review 7.  Natural products as modulators of eukaryotic protein secretion.

Authors:  Hendrik Luesch; Ville O Paavilainen
Journal:  Nat Prod Rep       Date:  2020-02-18       Impact factor: 13.423

8.  Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.

Authors:  Weijing Cai; Ranjala Ratnayake; Michael H Gerber; Qi-Yin Chen; Yichao Yu; Hartmut Derendorf; Jose G Trevino; Hendrik Luesch
Journal:  Invest New Drugs       Date:  2018-08-03       Impact factor: 3.850

9.  Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.

Authors:  Weijing Cai; Qi-Yin Chen; Long H Dang; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2017-09-18       Impact factor: 4.345

10.  Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.

Authors:  Victor Van Puyenbroeck; Eva Pauwels; Becky Provinciael; Thomas W Bell; Dominique Schols; Kai-Uwe Kalies; Enno Hartmann; Kurt Vermeire
Journal:  Traffic       Date:  2019-11-25       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.